Edmarcia E. De Souza
Sao Paulo, SP 05508000, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Molecular Characterization of Calu-3 Cells from Submerged to Air-Liquid Interface to Model Lung Infections.
Journal: Journal of proteome research
Published: January 28, 2026
Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine.
Journal: Frontiers in immunology
Published: April 12, 2025
Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19.
Journal: Frontiers in pharmacology
Published: April 08, 2024
High Target Homology Does Not Guarantee Inhibition: Aminothiazoles Emerge as Inhibitors of Plasmodium falciparum.
Journal: ACS infectious diseases
Published: February 17, 2024
Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein.
Journal: Vaccines
Published: January 24, 2024
Editorial: Emerging human viruses with pandemic potential: Diagnostics, pathogenesis, and therapeutics.
Journal: Frontiers in cellular and infection microbiology
Published: March 08, 2023
Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice.
Journal: Viruses
Published: February 21, 2023
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections.
Journal: Communications biology
Published: January 12, 2023
Protein Arginylation Is Regulated during SARS-CoV-2 Infection.
Journal: Viruses
Published: October 26, 2022
Hemorrhagic fever viruses: Pathogenesis, therapeutics, and emerging and re-emerging potential.
Journal: Frontiers in microbiology
Published: September 08, 2022
Last Updated: 09/26/2026